Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-021943·ArriVent BioPharma, Inc.
Schedule 13G ownership disclosure
ArriVent BioPharma, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 0472N1020
Event date: 2025-06-30
- Filing-level shares
- 1,872,142.00
- Percent of class
- 4.9%
- Novo Holdings A/S
Shares: 1,872,142.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021943
- Form type
- SCHEDULE 13G/A
- Filer
- ArriVent BioPharma, Inc.
- CIK
- CIK 1868279
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership